Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000454 · ClinicalTrials.gov registry record · Phase 4
Smoking Cessation in Alcoholism Treatment
A Phase 4 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 112
- Enrollment target
NCT00000454 is a Phase 4 study that has completed, run by Yale University. The registered enrollment target is 112 participants.
The verdict
NCT00000454, a Phase 4 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 112 participants
- Enrollment target
Study Summary
This study is designed to increase understanding of the processes that affect the treatment outcome of individuals with both alcohol and nicotine dependence. Treatment outcome methodology will be combined with a computerized self-monitoring methodology to examine the extent to which smoking serves as a cue for alcohol craving and/or as a response to alcohol craving in treated alcoholics. Subjects will be veterans participating in the Substance Abuse Day Programs at the Newington and West Haven campuses of the VA Connecticut Healthcare System. Nonveteran women will be recruited from the community and enrolled in the day program. Subjects will be randomly assigned to one of the following two conditions: (1) intensive smoking cessation therapy (counseling plus nicotine replacement using nicotine patches) concurrent with alcohol treatment, or (2) brief smoking cessation advice concurrent with alcohol treatment.
Interventions
- DRUG nicotine replacement patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Est. Completion | 2002-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000454
The ClinicalTrials.gov registry entry for NCT00000454 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which nicotine replacement patch is the first listed.
NCT00000454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000454 about?
NCT00000454 is a clinical study titled "Smoking Cessation in Alcoholism Treatment". This study is designed to increase understanding of the processes that affect the treatment outcome of individuals with both alcohol and nicotine dependence. Treatment outcome methodology will be combined with a computerized self-monitoring methodology to examine the extent to which smoking serves a...
What is the current status of trial NCT00000454?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 112 participants. Estimated completion is 2002-08.
What interventions are being tested in trial NCT00000454?
The interventions under investigation include: nicotine replacement patch (DRUG).
Who is sponsoring clinical trial NCT00000454?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.